+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Needle Free Injector Market- Strategies and Market Share and Industry Forecast to 2026

  • ID: 5398461
  • Report
  • August 2021
  • Region: Global
  • 1203 Pages
  • Strategies and Markets

FEATURED COMPANIES

  • Antares Pharma, Inc.
  • Crossject SA
  • Endo International plc
  • European Pharma Group
  • INJEX Pharma AG
  • PenJet Corporation
  • MORE

Global needle-free injectors market is primarily driven by increasing prevalence of chronic diseases and technological advancements. In addition, demand for innovative and effective drug delivery platform, owing to increase in prevalence of chronic diseases and rise of point-of-care are major factors triggering growth for the needle-free injectors market. However, there are certain challenges such as availability of alternative drug delivery platform. For instance, in 2017, FDA approved the first digital pill that is sensor embedded and leads to track the ingestion of medications inside the body. Moreover, in 2018, Rani Therapeutics (US) secured a funding of $53 million from various investors that include GeneScience Pharmaceuticals (China) and Shire (Europe) for manufacturing robotic pills for clinical trials. The robotic pill developed by the company can inject drugs directly into the small intestine. This can emerge as a safe and pain-free alternative technology for delivery of injectable drugs. Thus, technological advancements and the new product launch in the needle-free injectors market is expected to drive market growth over the forecast period. 

Global needle-free injectors market has been segmented based on application, site of delivery, end-user, type of medication, usability, product and technology. The technology segment is sub-segmented into jet injectors, spring, laser, vibration-based needle-free injectors. Jet injectors is the leading segment in terms of revenue in global needle-free injectors market with around 42% market share. The dominance of the jet injectors segment is primarily attributed to introduction of novel jet injectors due to the rise in the prevalence of chronic diseases. According to World Economic Forum (2017), 1 in 3 adults across the world has multiple chronic conditions such as diabetes, cardiovascular disease, cancer, depression etc. The high prevalence of these diseases is creating a demand for novel needle-free injectors. Moreover, spring-based needle free injector segment is anticipated to grow at the highest CAGR of around 15.2% during the forecast period. The fastest growth rate of transdermal patch segment is contributed by emergence of novel technology.

Geographically, the needle-free injectors market has been segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). Asia Pacific is expected to grow at the highest CAGR of 15.3%. Asia Pacific needle-free injectors market growth is because of the rising prevalence of chronic diseases in countries such as China, India, etc. along with government support for the development of advanced drug delivery technologies. China holds the largest market share of around 34% in 2019 in Asia Pacific needle-free injectors market. High R&D investment by companies in drug delivery technologies sector in China is boosting growth in needle-free injectors market owing to high prevalence of cancer in the region.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Antares Pharma, Inc.
  • Crossject SA
  • Endo International plc
  • European Pharma Group
  • INJEX Pharma AG
  • PenJet Corporation
  • MORE

1. Acknowledgment
1.1. Study, Objective & Scope
1.2. Information Sources 
1.3. Methodology

2. Summary
2.1. Market Size
2.2. Market Overview

3. Industry Outlook
3.1. Technology Review 
3.2. Market Dynamics & Trend Analysis
3.2.1. Opportunities
3.2.2. Trends
3.2.3. Challenges
3.3. Covid-19 Impact Analysis
3.4. Business Environment Analysis
3.4.1. Porter 5 Force Analysis

4. Market Share Analysis

5. Regulatory Landscape: Needle Free Injector

6. Analysing Needle Free Injector 
6.1. Needle Free Injector Product
6.1.1. Fillable Needle Free Injector
6.1.2. Prefilled Needle Free Injector
6.2. Needle Free Injector Medication Type 
6.2.1. Liquid-Based Needle Free Injectors
6.2.2. Powder-Based Needle Free Injectors
6.2.3. Projectile/Depot-Based Needle Free Injectors
6.3. Needle Free Injector Applications 
6.3.1. Vaccine Needle-Free Injectors 
6.3.2. Insulin Needle-Free Injectors 
6.3.3. Pain Management 
6.3.4. Others 
6.4. Needle Free Injector Usability 
6.4.1. Disposable Needle Free Injector
6.4.2. Reusable Needle Free Injector
6.5. Needle Free Injector End User 
6.5.1. Home Care Settings
6.5.2. Hospitals & Clinics
6.5.3. Others

7. Analysing Needle Free Injector Cross Borders
7.1. North America
7.1.1. United States
7.1.2. Canada
7.2. Europe
7.2.1. United Kingdom
7.2.2. Germany 
7.2.3. France
7.2.4. Russia
7.2.5. Rest of Europe
7.3. Asia Pacific 
7.3.1. China
7.3.2. India
7.3.3. Japan
7.3.4. Australia
7.3.5. Rest of Asia Pacific
7.4. Rest of The World
7.4.1. Latin America
7.4.2. Middle East & Africa

8. Competitive Landscape
8.1. Strategies Snapshot

9. Patent Analysis
9.1. Company Analysis
9.2. Component Analysis

10. Company Profiling 
10.1. Activa Brand Products, Inc
10.2. Antares Pharma, Inc.
10.3. Bioject Medical Technologies Inc. 
10.4. Crossject SA 
10.5. Endo International plc 
10.6. European Pharma Group 
10.7. INJEX Pharma AG 
10.8. Medical International Technology, Inc. 
10.9. National Medical Products Inc. 
10.10. PenJet Corporation 
10.11. PharmaJet 
10.12. Valeritas, Inc. 

List of Tables & Figures
1. Global Needle Free Injector Market 2019-2026 ($ Million)
2. Global Needle Free Injector Market By Application 2019-2026 ($ Million)
3. Global Vaccine Delivery Market By Geography 2019-2026 ($ Million)
4. Global Insulin Delivery Market By Geography 2019-2026 ($ Million)
5. Global Pain Management Market By Geography 2019-2026 ($ Million)
6. Global Other Market By Geography 2019-2026 ($ Million)
7. Global Needle Free Injector Market By Product 2019-2026 ($ Million)
8. Global Fillable Needle Free Injector Market By Geography 2019-2026 ($ Million)
9. Global Prefilled Needle Free Injector Market By Geography 2019-2026 ($ Million)
10. Global Needle Free Injector Market By Technology 2019-2026 ($ Million)
11. Global Jet-Based Needle Free Injector Market By Geography 2019-2026 ($ Million)
12. Global Spring-Based Needle Free Injector Market By Geography 2019-2026 ($ Million) 
13. Global Laser-Powered Needle-Free Injectors Market By Geography 2019-2026 ($ Million)
14. Global Vibration -Based Needle Free Injector Market By Geography 2019-2026 ($ Million) 
15. Global Needle Free Injector Market By Usability 2019-2026 ($ Million)
16. Global Disposable Needle Free Injector Market By Geography 2019-2026 ($ Million)
17. Global Reusable Needle Free Injector Market By Geography 2019-2026 ($ Million)
18. Global Needle-Free Injectors Market By End Users 2019-2026 ($ Million)
19. Global Hospitals & Clinics Market By Geography 2019-2026 ($ Million)
20. Global Home Care Settings Market By Geography 2019-2026 ($ Million) 
21. Global Other End User Market By Geography 2019-2026 ($ Million)
22. Global Needle-Free Injectors Market By Type Of Medication 2019-2026 ($ Million)
23. Global Liquid-Based Needle-Free Injectors Market By Geography 2019-2026 ($ Million)
24. Global Powder-Based Needle-Free Injectors Market By Geography 2019-2026 ($ Million)
25. Global Projectile/Depot-Based Needle-Free Injectors Market By Geography 2019-2026 ($ Million)
26. North America Needle Free Injector Market 2019-2026 ($ Million)
27. United States Needle Free Injector Market 2019-2026 ($ Million)
28. Canada Needle Free Injector Market 2019-2026 ($ Million)
29. Europe Needle Free Injector Market 2019-2026 ($ Million)
30. United Kingdom Needle Free Injector Market 2019-2026 ($ Million)
31. Germany Needle Free Injector Market 2019-2026 ($ Million)
32. France Needle Free Injector Market 2019-2026 ($ Million)
33. Russia Needle Free Injector Market 2019-2026 ($ Million)
34. Rest of Europe Needle Free Injector Market 2019-2026 ($ Million)
35. Asia Pacific Needle Free Injector Market 2019-2026 ($ Million)
36. China Needle Free Injector Market 2019-2026 ($ Million)
37. India Needle Free Injector Market 2019-2026 ($ Million)
38. Japan Needle Free Injector Market 2019-2026 ($ Million)
39. Australia Needle Free Injector Market 2019-2026 ($ Million)
40. Rest of Asia Pacific Needle Free Injector Market 2019-2026 ($ Million)
41. Rest of The World Needle Free Injector Market 2019-2026 ($ Million)
42. Latin America Needle Free Injector Market 2019-2026 ($ Million)
43. Middle East & Africa Needle Free Injector Market 2019-2026 ($ Million)

Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • Antares Pharma, Inc.
  • Crossject SA
  • Endo International plc
  • European Pharma Group
  • INJEX Pharma AG
  • PenJet Corporation
  • MORE

The global needle free injector market is expected to hace a CAGR of 16.1% during forecast period 2019-2026. The key factors driving the market growth are increasing incidence of chronic diseases, rising incidence of communicable diseases due to needle stick injuries, growing demand for self-injection devices and advantages of drug delivery technology. 
Geographically, North America accounts for highest revenue share of the needle free injector market. The key factor contributing to the North American needle free injector market is increasing cases of chronic diseases such as cancer, Alzheimer’s, stroke, etc. However, Europe is anticipated to emerge as the fastest growing market during forecast period owing to rising demand for biologics in European region.

The global needle free injector market is influenced by the presence of key market players such as Endo international PLC, Crossject, Astrazeneca, Asia Pharma Pharmaceutical ltd. etc. Product launch, joint venture, merger and acquisition are some of the crucial strategies adopted by the key market players to gain competitive advantage.

Global needle free injector market report covers segmentation analysis of technologies, site of delivery, types of medication, usability, end users and applications. Report further covers segments of technology which include jet-based, laser-powered, spring-based and vibration-based needle free injector. The jet based needle free injector is the dominating segment owing to its advantages over other technologies. Report further covers segments of site of delivery which include intra dermal injectors, intramuscular injectors and subcutaneous injectors. Types of medication include Liquid-based, Powder-based and Projectile/depot-based needle free injectors. Liquid based needle free injector is the leading medication segment as it is flexible to use. The end users of needle free injector are hospital and clinics, home care settings, research laboratories and others.

Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Activa Brand Products, Inc
  • Antares Pharma, Inc.
  • Bioject Medical Technologies Inc. 
  • Crossject SA 
  • Endo International plc 
  • European Pharma Group 
  • INJEX Pharma AG 
  • Medical International Technology, Inc. 
  • National Medical Products Inc. 
  • PenJet Corporation 
  • PharmaJet 
  • Valeritas, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll